产品编号：L469913
产品规格：100mg
产品价格：面议
| 标准品编号: | L469913 |
| 名称: | Lorglumide |
| 别名: | DL-4-(3,4-Dichlorobenzoylamino)-5-(dipentylamino)-5-oxopentanoic Acid; 4-[(3,4-Dichlorobenzoyl)amino]-5-(dipentylamino)-5-oxopentanoic Acid; CR 1409; (±)-4-[(3,4-Dichlorobenzoyl)amino]-5-(dipentylamino)-5-oxo-pentanoic Acid; 4-[(3,4-Dichlorobenzoyl)amino]-5-(dipentylamino)-5-oxo-pentanoic Acid |
| CAS号: | 97964-56-2 |
| 分子式: | C₂₂H₃₂Cl₂N₂O₄ |
| 外观: | 白色固体 |
| 分子量: | 459.41 |
| 溶解度: | Dichloromethane, Methanol |
| 种类: | Standards; Pharmaceutical/API Drug Impurities/Metabolites; |
| 应用: | Lorglumide is a specific cholecytokinin receptor antagonist. It is also an intermediate in synthesizing Lorglumide Sodium Salt (L469910), a nonpeptidic antagonist of the CCK A receptor, and minimally effective at the CCK B receptor. It blocks CCK -mediated muscle contraction, pancreatic growth and secretion. |
| 参考文献 | |
